% Expired Patents = 25.0

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Bernhard Keppler (2 out of 8 patents)

Hooshmand Sheshbaradaran (1 out of 6 patents)

Berhhard Keppler (1 out of 1 patent)

4. William McCulloch (1 patent)

5. Bernhard Keppler (0 patent)

6. Rebecca Baerga (0 patent)

7. Jenel Cobb (0 patent)

8. Aram Prokop (0 patent)

9. Soo-Young Lee (0 patent)

10. Seied Mojtaba Valiahdi (0 patent)

4 patents: Sort by Forward Citations

1. 9283208 - Medicaments and methods for treating cancer (2016-03-15),

2. 8362266 - Method of manufacturing a ruthenium complex (2013-01-29),

3. 7919486 - Use of gallium(III) complexes for the treatment of melanomas (2011-04-05),

4. 7589084 - Anticancer compositions, and methods of making and using the same (2009-09-15),

Company Overview

Niiki Pharma Inc. is a pharmaceutical company focused on developing innovative therapies for various medical conditions. With a strong emphasis on research and development, Niiki Pharma is dedicated to improving patient outcomes and quality of life. The company is committed to advancing healthcare through cutting-edge technology and collaboration with industry experts. Visit our website to learn more about our mission and portfolio of products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#19 in Hoboken, NJ

#2,205 in New Jersey

#60,671 in US

Hoboken, NJ, United States of America

Niiki Pharma Inc.

Forward Citations = 4

3 inventors:

Bernhard Keppler (2 out of 8 patents)

Hooshmand Sheshbaradaran (1 out of 6 patents)

Berhhard Keppler (1 out of 1 patent)

4. William McCulloch (1 patent)

5. Bernhard Keppler (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Niiki Pharma Inc.. Retrieved from https://idiyas.com/company/niiki-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]